| Mutation in the α-synuclein gene identified in families with Parkinson's disease MH Polymeropoulos, C Lavedan, E Leroy, SE Ide, A Dehejia, A Dutra, ... science 276 (5321), 2045-2047, 1997 | 10102 | 1997 |
| Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19* 2 genotyping D Alexopoulos, G Dimitropoulos, P Davlouros, I Xanthopoulou, ... JACC: Cardiovascular Interventions 4 (4), 403-410, 2011 | 163 | 2011 |
| Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding α-synuclein A Athanassiadou, G Voutsinas, L Psiouri, E Leroy, MH Polymeropoulos, ... The American Journal of Human Genetics 65 (2), 555-558, 1999 | 163 | 1999 |
| Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element EP Papapetrou, PG Ziros, ID Micheva, NC Zoumbos, A Athanassiadou Gene therapy 13 (1), 40-51, 2006 | 115 | 2006 |
| The Ala53Thr mutation in the α‐synuclein gene in a Korean family with Parkinson disease CS Ki, EF Stavrou, N Davanos, WY Lee, EJ Chung, JY Kim, ... Clinical genetics 71 (5), 471-473, 2007 | 85 | 2007 |
| Clinical phenotype in patients with α-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease S Papapetropoulos, C Paschalis, A Athanassiadou, A Papadimitriou, ... Journal of Neurology, Neurosurgery & Psychiatry 70 (5), 662-665, 2001 | 82 | 2001 |
| Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects EP Papapetrou, NC Zoumbos, A Athanassiadou Gene therapy 12 (1), S118-S130, 2005 | 78 | 2005 |
| Genetic assessment of familial and early‐onset Parkinson's disease in a Greek population M Bozi, D Papadimitriou, R Antonellou, M Moraitou, M Maniati, ... European journal of neurology 21 (7), 963-968, 2014 | 73 | 2014 |
| Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and … E Yannaki, T Papayannopoulou, E Jonlin, F Zervou, G Karponi, ... Molecular Therapy 20 (1), 230-238, 2012 | 72 | 2012 |
| Motor and nonmotor features of carriers of the p. A53T alpha‐synuclein mutation: a longitudinal study D Papadimitriou, R Antonelou, M Miligkos, M Maniati, N Papagiannakis, ... Movement Disorders 31 (8), 1226-1230, 2016 | 69 | 2016 |
| Allelic imbalance of expression and epigenetic regulation within the alpha‐synuclein wild‐type and p. Ala53Thr alleles in Parkinson disease GE Voutsinas, EF Stavrou, G Karousos, A Dasoula, A Papachatzopoulou, ... Human mutation 31 (6), 685-691, 2010 | 66 | 2010 |
| Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane E Pipili‐Synetos, S Kritikou, E Papadimitriou, A Athanassiadou, ... British journal of pharmacology 129 (1), 207-213, 2000 | 62 | 2000 |
| Emerging patent landscape for non-viral vectors used for gene therapy V Picanço-Castro, CG Pereira, DT Covas, GS Porto, A Athanassiadou, ... Nature biotechnology 38 (2), 151-157, 2020 | 58 | 2020 |
| CYP2C19* 2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention G Kassimis, P Davlouros, I Xanthopoulou, EF Stavrou, A Athanassiadou, ... Thrombosis research 129 (4), 441-446, 2012 | 52 | 2012 |
| Mutation screening of the Wolfram syndrome gene in psychiatric patients R Torres, E Leroy, X Hu, A Katrivanou, P Gourzis, A Papachatzopoulou, ... Molecular Psychiatry 6 (1), 39-43, 2001 | 51 | 2001 |
| Prasugrel versus high dose clopidogrel to overcome early high on clopidogrel platelet reactivity in patients with ST elevation myocardial infarction D Alexopoulos, KC Theodoropoulos, EF Stavrou, I Xanthopoulou, ... Cardiovascular drugs and therapy 26, 393-400, 2012 | 48 | 2012 |
| Thalassaemia mutations within the 5′UTR of the human β‐globin gene disrupt transcription A Sgourou, S Routledge, M Antoniou, A Papachatzopoulou, L Psiouri, ... British journal of haematology 124 (6), 828-835, 2004 | 47 | 2004 |
| Genotypic heterogeneity and correlation to intergenic haplotype within high HbF β‐thalassemia intermedia A Papachatzopoulou, A Kourakli, P Makropoulou, T Kakagianne, ... European journal of haematology 76 (4), 322-330, 2006 | 40 | 2006 |
| Environmental mycobacteria in drinking water before and after replacement of the water distribution network A Tsintzou, A Vantarakis, O Pagonopoulou, A Athanassiadou, ... Water, air, and soil pollution 120, 273-282, 2000 | 39 | 2000 |
| A novel β‐thalassaemia mutation in the 5’untranslated region of the β‐globin gene A Athanassiadou, A Papachatzopoulou, N Zoumbos, GM Maniatis, ... British journal of haematology 88 (2), 307-310, 1994 | 38 | 1994 |
